BALLARD PARTNERS

Lobbying for MERCK SHARP & DOHME LLC · Biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · $50,000.00 income · posted Oct 16, 2025

Lobbying activity 2

Pharmacy

Guidance and advocacy related to drug pricing and tariffs.

Tariff (miscellaneous tariff bills)

Guidance and advocacy related to drug pricing and tariffs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.